High-frequency generation of altered Mr 70,000 env glycoproteins in N-methyl-N'-nitro-N-nitrosoguanidine-treated murine tumor cells
- PMID: 3342395
High-frequency generation of altered Mr 70,000 env glycoproteins in N-methyl-N'-nitro-N-nitrosoguanidine-treated murine tumor cells
Abstract
In previous studies we have characterized variant clones established following treatment of mouse Eb lymphoma cells with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Some of these clones were impaired in tumorigenicity due to an increased immunogenicity (tum- phenotype). In this paper we investigated the mutagenic effect of MNNG on cell surface molecules. The results show that retroviral Mr 70,000 glycoprotein (gp70) antigens undergo extensive alterations following MNNG treatment. In five of five mutant clones analyzed, the two-dimensional gel electrophoretic patterns of gp70 antigens were altered in comparison to the parental Eb cells. Peptide mapping analysis of immunoprecipitated gp70 molecules using three different enzymes revealed detectable changes in amino acid sequence in three of five mutant clones. In contrast, no alterations were detected in H-2Kd and H-2Dd antigens of the same clones. The gp70 antigens expressed by mutant clones could be resolved in three distinct clusters. Only one cluster induced antibodies in the syngeneic host. When genomic DNAs of MNNG clones were investigated by Southern blot analysis using a gp70-specific probe, an additional 4.5-kilobase hybridizing band could be detected that was not present in parental Eb cells and 5'-azacytidine-treated Eb clones. Collectively, our results show that gp70 antigens and genes are affected by MNNG treatment with high frequency. The possible role of structurally altered gp70 molecules in the immunogenicity of mutagenized tumor cells is discussed.
Similar articles
-
Endogenous retroviral env genes after N-methyl-N'-nitro-N-nitrosoguanidine treatment of mouse tumor cells: stable DNA amplification and rearrangement.Cancer Res. 1989 Jul 15;49(14):3966-71. Cancer Res. 1989. PMID: 2736535
-
Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens.Cancer Res. 1985 Sep;45(9):4270-7. Cancer Res. 1985. PMID: 4028013
-
Effects of mutagens on the immunogenicity of tumor cells: comparison of cell surface changes induced by 5-azacytidine and N-methyl-N'-nitro-N-nitrosoguanidine.Cancer Res. 1986 Jun;46(6):2912-6. Cancer Res. 1986. PMID: 2421887
-
The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.J Immunol. 1986 Mar 15;136(6):2271-9. J Immunol. 1986. PMID: 3005407
-
Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment.J Cell Physiol Suppl. 1984;3:87-97. doi: 10.1002/jcp.1041210411. J Cell Physiol Suppl. 1984. PMID: 6205005 Review.
Cited by
-
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Oncotarget. 2017 Jun 20;8(25):41641-41669. doi: 10.18632/oncotarget.16335. Oncotarget. 2017. PMID: 28404974 Free PMC article. Review.
-
Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens.Cancer Immunol Immunother. 1989;29(2):139-43. doi: 10.1007/BF00199289. Cancer Immunol Immunother. 1989. PMID: 2470506 Free PMC article.
-
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents.Cancer Chemother Pharmacol. 1992;29(4):277-82. doi: 10.1007/BF00685945. Cancer Chemother Pharmacol. 1992. PMID: 1537073